Development of Intermediate Layer with Improved Diffusional Barrier
Lek Pharmaceuticals,d.d., Sandoz Development Center Slovenia, Verovškova 57, 1526 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 717; https://doi.org/10.3797/scipharm.cespt.8.POT02
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Delayed release dosage form development usually requires an effective intermediate layer for separation of acid liable drug and acidic gastric polymer. [...]
Share and Cite
MDPI and ACS Style
JAKLIČ, M.T.; JUREČIČ, R. Development of Intermediate Layer with Improved Diffusional Barrier. Sci. Pharm. 2010, 78, 717. https://doi.org/10.3797/scipharm.cespt.8.POT02
AMA Style
JAKLIČ MT, JUREČIČ R. Development of Intermediate Layer with Improved Diffusional Barrier. Scientia Pharmaceutica. 2010; 78(3):717. https://doi.org/10.3797/scipharm.cespt.8.POT02
Chicago/Turabian StyleJAKLIČ, M. T., and R. JUREČIČ. 2010. "Development of Intermediate Layer with Improved Diffusional Barrier" Scientia Pharmaceutica 78, no. 3: 717. https://doi.org/10.3797/scipharm.cespt.8.POT02
